GRPs and BBN share the same heptapeptide sequence at the C-terminus, which has been used as the targeting vector for the design of GRPR-targeting radiopharmaceuticals for cancer diagnosis and radioligand therapy for decades [14,15,16,17,18,19,20,21]. This evidence concerns the gene GRPR and cancer.